Published in Circulation on May 29, 2001
Ultrasound contrast microbubbles in imaging and therapy: physical principles and engineering. Phys Med Biol (2009) 2.27
Echocardiography in translational research: of mice and men. J Am Soc Echocardiogr (2008) 1.84
Microbubble ultrasound contrast agents: an update. Eur Radiol (2007) 1.57
Reduced 123I-BMIPP uptake implies decreased myocardial flow reserve in patients with chronic stable angina. Eur J Nucl Med Mol Imaging (2005) 1.39
Infusing lipid raises plasma free fatty acids and induces insulin resistance in muscle microvasculature. J Clin Endocrinol Metab (2009) 1.30
Angiotensin II type 1 and type 2 receptors regulate basal skeletal muscle microvascular volume and glucose use. Hypertension (2009) 1.18
Free fatty acids induce insulin resistance in both cardiac and skeletal muscle microvasculature in humans. J Clin Endocrinol Metab (2010) 1.16
Application of a second-generation US contrast agent in infants and children--a European questionnaire-based survey. Pediatr Radiol (2012) 1.10
Assessment of tissue perfusion by contrast-enhanced ultrasound. Eur Radiol (2010) 1.07
Real-time measurement of renal blood flow in healthy subjects using contrast-enhanced ultrasound. Am J Physiol Renal Physiol (2009) 1.05
Combination of contrast with stress echocardiography: a practical guide to methods and interpretation. Cardiovasc Ultrasound (2004) 0.95
Ventricular remodeling and function: insights using murine echocardiography. J Mol Cell Cardiol (2009) 0.95
Resveratrol recruits rat muscle microvasculature via a nitric oxide-dependent mechanism that is blocked by TNFα. Am J Physiol Endocrinol Metab (2010) 0.92
Relationship between myocardial perfusion and dysfunction in diabetic cardiomyopathy: a study of quantitative contrast echocardiography and strain rate imaging. Heart (2006) 0.90
Effect of streptozotocin-induced diabetes on myocardial blood flow reserve assessed by myocardial contrast echocardiography in rats. Cardiovasc Diabetol (2008) 0.88
Myocardial blood volume is associated with myocardial oxygen consumption: an experimental study with cardiac magnetic resonance in a canine model. JACC Cardiovasc Imaging (2009) 0.88
Adenosine myocardial contrast echo in intermediate severity coronary stenoses: a prospective two-center study. Int J Cardiovasc Imaging (2006) 0.88
Contrast echocardiography in Canada: Canadian Cardiovascular Society/Canadian Society of Echocardiography position paper. Can J Cardiol (2007) 0.88
Novel ultrasound and DCE-MRI analyses after antiangiogenic treatment with a selective VEGF receptor inhibitor. Ultrasound Med Biol (2011) 0.85
Changes in transmural distribution of myocardial perfusion assessed by quantitative intravenous myocardial contrast echocardiography in humans. Heart (2002) 0.82
Quantification of global myocardial oxygenation in humans: initial experience. J Cardiovasc Magn Reson (2010) 0.81
Prognostic value of dipyridamole stress myocardial contrast echocardiography: comparison with single photon emission computed tomography. J Am Soc Echocardiogr (2009) 0.81
Cocaine-induced vasoconstriction in the human coronary microcirculation: new evidence from myocardial contrast echocardiography. Circulation (2013) 0.79
Imaging myocardial angiogenesis. Nat Rev Cardiol (2009) 0.79
Quantification of resting myocardial blood flow velocity in normal humans using real-time contrast echocardiography. A feasibility study. Cardiovasc Ultrasound (2005) 0.78
Coronary autoregulation is abnormal in syndrome X: insights using myocardial contrast echocardiography. J Am Soc Echocardiogr (2013) 0.78
Effect of modest alcohol consumption over 1-2 weeks on the coronary microcirculation of normal subjects. Eur J Echocardiogr (2010) 0.76
Perfusion imaging with vasodilator stress echocardiography: a physiologically sound approach to coronary disease? Circ Cardiovasc Imaging (2011) 0.75
Incremental value of contrast myocardial perfusion to detect intermediate versus severe coronary artery stenosis during stress-echocardiography. Cardiovasc Ultrasound (2010) 0.75
Abnormal Myocardial Blood Flow Reserve Observed in Cardiac Amyloidosis. J Cardiovasc Ultrasound (2016) 0.75
Predictive Value of Dobutamine Stress Perfusion Echocardiography in Contemporary End-Stage Liver Disease. J Am Heart Assoc (2017) 0.75
A comparison of video and digital data in the assessment of myocardial perfusion abnormalities by myocardial contrast echocardiography. Int J Cardiovasc Imaging (2004) 0.75
Sequence and analysis of chromosome 2 of the plant Arabidopsis thaliana. Nature (1999) 8.04
Evaluation of chest pain in the emergency department. Ann Intern Med (1994) 7.12
Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation (1998) 5.93
Genetic definition and sequence analysis of Arabidopsis centromeres. Science (1999) 4.20
Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation (2001) 3.15
Assessment of right ventricular function using two-dimensional echocardiography. Am Heart J (1984) 3.09
An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N Engl J Med (1992) 2.81
Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. J Natl Cancer Inst (1996) 2.51
Disinfection methods in general practice and health authority clinics: a telephone survey. J R Coll Gen Pract (1988) 2.41
Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue. Circulation (1998) 2.37
ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association. J Am Coll Cardiol (1999) 2.37
Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound. Circulation (1998) 2.30
Sequence and analysis of chromosome 3 of the plant Arabidopsis thaliana. Nature (2000) 2.17
American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on cardiac catheterization laboratory standards. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol (2001) 2.09
Noninvasive ultrasound imaging of inflammation using microbubbles targeted to activated leukocytes. Circulation (2000) 2.07
Geometric remodeling is not the principal pathogenetic process in restenosis after balloon angioplasty. Evidence from correlative angiographic-histomorphometric studies of atherosclerotic arteries in rabbits. Circulation (1994) 2.03
Pharmacokinetics of stavudine in patients with AIDS or AIDS-related complex. J Infect Dis (1992) 1.94
Use of sildenafil (Viagra) in patients with cardiovascular disease. Technology and Practice Executive Committee. Circulation (1999) 1.87
Sequence and analysis of chromosome 1 of the plant Arabidopsis thaliana. Nature (2000) 1.85
Physiologic hyperinsulinemia enhances human skeletal muscle perfusion by capillary recruitment. Diabetes (2001) 1.80
Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction. New insights using myocardial contrast echocardiography. Circulation (1994) 1.79
Quantification of renal blood flow with contrast-enhanced ultrasound. J Am Coll Cardiol (2001) 1.77
Contrast echocardiography: current and future applications. J Am Soc Echocardiogr (2000) 1.76
Inter- and intrapatient variability in etoposide kinetics with oral and intravenous drug administration. Clin Cancer Res (1999) 1.70
American College of Cardiology/American Heart Association Expert Consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. Circulation (2000) 1.69
Post-ischaemic myocardial dysfunction (stunning) results from myofibrillar oedema. Heart (2007) 1.67
Meningococcal disease in Wales: clinical features, outcome and public health management. J Infect (1992) 1.60
Sarcoglycanopathies: a clinico-pathological study. Neurol India (2007) 1.59
Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis. Lancet (1994) 1.59
Targeted ultrasound contrast agent for molecular imaging of inflammation in high-shear flow. Contrast Media Mol Imaging (2006) 1.58
Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation (1997) 1.55
Effect of salmeterol on respiratory muscle activity during exercise in poorly reversible COPD. Thorax (2004) 1.52
In vivo myocardial kinetics of air-filled albumin microbubbles during myocardial contrast echocardiography. Comparison with radiolabeled red blood cells. Circ Res (1994) 1.48
Association of tumor necrosis factor-α and matrix metalloproteinase-3 gene variants with stroke. Eur J Neurol (2011) 1.47
Complex mtDNA constitutes an approximate 620-kb insertion on Arabidopsis thaliana chromosome 2: implication of potential sequencing errors caused by large-unit repeats. Proc Natl Acad Sci U S A (2001) 1.47
Efficient utilization of echocardiography for the assessment of left ventricular systolic function. Am Heart J (2000) 1.46
Relationship between left ventricular wall thickness and left atrial size: comparison with other measures of diastolic function. J Am Soc Echocardiogr (1995) 1.46
Prevalence and pattern of major neurological disorders in rural Kashmir (India) in 1986. Neuroepidemiology (1994) 1.45
Extent and severity of coronary disease and mortality in patients with end-stage renal failure evaluated for renal transplantation. Am J Transplant (2009) 1.45
Angioscopic evaluation of incompletely obstructing coronary intraluminal filling defects: comparison to angiography. Cathet Cardiovasc Diagn (1994) 1.43
Noninvasive imaging of inflammation by ultrasound detection of phagocytosed microbubbles. Circulation (2000) 1.43
Microbubble persistence in the microcirculation during ischemia/reperfusion and inflammation is caused by integrin- and complement-mediated adherence to activated leukocytes. Circulation (2000) 1.39
Hollow-fiber unit evaluation of a new human immunodeficiency virus type 1 protease inhibitor, BMS-232632, for determination of the linked pharmacodynamic variable. J Infect Dis (2001) 1.38
A phase I/II evaluation of stavudine (d4T) in children with human immunodeficiency virus infection. Pediatrics (1995) 1.37
Effects of recombinant apolipoprotein A-I(Milano) on aortic atherosclerosis in apolipoprotein E-deficient mice. Circulation (1998) 1.34
Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis. J Clin Oncol (1992) 1.32
Interactions between microbubbles and ultrasound: in vitro and in vivo observations. J Am Coll Cardiol (1997) 1.31
Postoperative pain after cholecystectomy: Conventional laparoscopy versus single-incision laparoscopic surgery. J Minim Access Surg (2011) 1.30
Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: evidence for activation by proinflammatory mediators. Circulation (1999) 1.28
Functional significance of collateral blood flow in patients with recent acute myocardial infarction. A study using myocardial contrast echocardiography. Circulation (1992) 1.27
Encore, a gene required for the regulation of germ line mitosis and oocyte differentiation during Drosophila oogenesis. Development (1996) 1.27
The behavior of sonicated albumin microbubbles within the microcirculation: a basis for their use during myocardial contrast echocardiography. Circ Res (1989) 1.25
Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques. Magn Reson Imaging (1996) 1.25
Role of capillaries in determining CBF reserve: new insights using myocardial contrast echocardiography. Am J Physiol (1999) 1.24
In vitro and in vivo disposition and metabolism of 3'-deoxy-2',3'-didehydrothymidine. Antimicrob Agents Chemother (1993) 1.23
Management of sexual dysfunction in patients with cardiovascular disease: recommendations of The Princeton Consensus Panel. Am J Cardiol (2000) 1.20
Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing is coming, part I. Circulation (2001) 1.19
Decreased neointimal thickening after arterial wall injury in inducible nitric oxide synthase knockout mice. Circ Res (2000) 1.19
Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure. J Am Coll Cardiol (1999) 1.19
Basis for detection of stenosis using venous administration of microbubbles during myocardial contrast echocardiography: bolus or continuous infusion? J Am Coll Cardiol (1998) 1.19
Acute transverse myelitis: MR characteristics. Neurol India (1999) 1.18
Brain metastasis model in athymic nude mice using a novel MUC1-secreting human breast-cancer cell line, MA11. Int J Cancer (1996) 1.15
Echocardiographic and phonocardiographic characteristics of the lillehei-kaster mitral valve prosthesis. Circulation (1974) 1.13
Effect of acute hyperglycaemia, long-term glycaemic control and insulin on endothelial dysfunction and inflammation in Type 1 diabetic patients with different characteristics. Diabet Med (2010) 1.13
Assessment of resting perfusion with myocardial contrast echocardiography: theoretical and practical considerations. Am Heart J (2000) 1.13
Effect of chronic subcutaneous or intramural administration of heparin on femoral artery restenosis after balloon angioplasty in hypercholesterolemic rabbits. A quantitative angiographic and histopathological study. Circulation (1992) 1.12
Tenascin-C is expressed in macrophage-rich human coronary atherosclerotic plaque. Circulation (1999) 1.12
Diagnostic value of echocardiography in suspected endocarditis. An evaluation based on the pretest probability of disease. Circulation (1996) 1.11
Noninvasive prediction of ultimate infarct size at the time of acute coronary occlusion based on the extent and magnitude of collateral-derived myocardial blood flow. Circulation (2001) 1.11
Primary fibrosarcoma of brain. Neurol India (2000) 1.10
Prediction of outcome after mitral valve replacement in patients with symptomatic chronic mitral regurgitation. The importance of left atrial size. Circulation (1991) 1.10
Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages. Circulation (1999) 1.09
Arterial injury increases expression of inflammatory adhesion molecules in the carotid arteries of apolipoprotein-E-deficient mice. J Vasc Res (1999) 1.08
Identification of the Escherichia coli lytB gene, which is involved in penicillin tolerance and control of the stringent response. J Bacteriol (1993) 1.08
Population pharmacokinetics of stavudine (d4T) in patients with AIDS or advanced AIDS-related complex. Antimicrob Agents Chemother (1995) 1.08
High-performance liquid chromatographic determination of 2',3'-didehydro-3'-deoxythymidine, a new anti-human immunodeficiency virus agent, in human plasma and urine. J Chromatogr (1992) 1.07
Value of regional wall motion abnormality in the emergency room diagnosis of acute myocardial infarction. A prospective study using two-dimensional echocardiography. Circulation (1991) 1.07
Is it multiple sclerosis or not? Neurology (2001) 1.06
Changes in myocardial blood volume with graded coronary stenosis. Am J Physiol (1997) 1.05
Perivascular delivery of a nitric oxide donor inhibits neointimal hyperplasia in vein grafts implanted in the arterial circulation. J Thorac Cardiovasc Surg (1998) 1.05
Blood glucose and platelet-dependent thrombosis in patients with coronary artery disease. J Am Coll Cardiol (2000) 1.04
Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer. Int J Cancer (1998) 1.04
Quantification of cerebral perfusion with "Real-Time" contrast-enhanced ultrasound. Circulation (2001) 1.03
Effects of radiofrequency catheter ablation on regional myocardial blood flow. Possible mechanism for late electrophysiological outcome. Circulation (1994) 1.03
Characterization of spatial patterns of flow within the reperfused myocardium by myocardial contrast echocardiography. Implications in determining extent of myocardial salvage. Circulation (1993) 1.03
Coronary and myocardial blood volumes: noninvasive tools to assess the coronary microcirculation? Circulation (1997) 1.03
Non-invasive ventilation in chronic obstructive pulmonary disease: management of acute type 2 respiratory failure. Clin Med (2008) 1.02
Identification of eukaryotic parvulin homologues: a new subfamily of peptidylprolyl cis-trans isomerases. Biochem Biophys Res Commun (1999) 1.01
Changes in myocardial blood volume over a wide range of coronary driving pressures: role of capillaries beyond the autoregulatory range. Heart (2004) 1.01
Recent advances in myocardial contrast echocardiography. Curr Opin Cardiol (1997) 1.01
Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection. J Am Coll Cardiol (1996) 1.00
Myocardial perfusion imaging in the setting of coronary artery stenosis and acute myocardial infarction using venous injection of a second-generation echocardiographic contrast agent. Circulation (1997) 1.00
Functional improvement precedes structural regression of atherosclerosis. Circulation (1994) 1.00